The cardioprotective mechanisms of eicosapentaenoic acid in heart failure are related to its ability to activate NRF2 (nuclear factor erythropoietin 2 related factor 2), Ffar4 receptor (free fatty acid receptor 4), or GPR120 fibroblast receptors. This evidence concerns the gene FFAR4 and heart failure.